Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | SELP | P16109 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21012244 | 1.00 | FNTA (0.47) | FNTAFNTBFAAHSELPCNR1 | |
| SCHEMBL13253388 | 1.00 | FNTA (0.47) | FNTAFNTBFAAHSELPCNR1 | |
| SCHEMBL18064494 | 0.92 | CNR1 (0.58) | FAAHCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL16566153 | 0.92 | CNR1 (0.58) | FAAHCNR1ALDH1A1HPGDTRPV1 | |
| SCHEMBL13253389 | 0.90 | FNTA (0.49) | FNTAFNTBFAAHMEN1KMT2A | |
| SCHEMBL10796126 | 0.89 | CNR1 (0.50) | FNTAFNTBFAAHSELPCNR1 | |
| SCHEMBL21473675 | 0.86 | GLP1R (0.45) | FNTAFNTBMEN1MAPTKMT2A | |
| SCHEMBL24237015 | 0.85 | GLP1R (0.44) | FNTAFNTBMEN1MAPTKMT2A | |
| SCHEMBL7865417 | 0.85 | PLA2G2A (0.55) | FNTAFNTBALDH1A1MEN1KMT2A | |
| SCHEMBL2638784 | 0.81 | FFAR4 (0.44) | FAAHMEN1KMT2ACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080268077-A1 | Process for Strengthening the Barrier Function of Undamaged Skin | SYMRISE GMBH & CO. KG (DE) | 2008-10-30 | — | — | US | claimed |
| EP-1802272-A1 | PROCESS FOR STRENGTHENING THE BARRIER FUNCTION OF UNDAMAGED SKIN | Symrise GmbH & Co. KG (DE) | 2007-07-04 | — | — | EP | claimed |
| WO-2006040349-A1 | PROCESS FOR STRENGTHENING THE BARRIER FUNCTION OF UNDAMAGED SKIN | SYMRISE GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | claimed |
| US-20080268077-A1 | Process for Strengthening the Barrier Function of Undamaged Skin | SYMRISE GMBH & CO. KG (DE) | 2008-10-30 | — | — | US | disclosed |
| EP-1802272-A1 | PROCESS FOR STRENGTHENING THE BARRIER FUNCTION OF UNDAMAGED SKIN | Symrise GmbH & Co. KG (DE) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006040349-A1 | PROCESS FOR STRENGTHENING THE BARRIER FUNCTION OF UNDAMAGED SKIN | SYMRISE GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080268077-A1 | Process for Strengthening the Barrier Function of Undamaged Skin | CERT1, CERS2, SGMS2 | FNTA 963/4885FNTB 993/4885FAAH 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.